A Study of Immune System Activity Cycles in Patients with Surgically Removed Early Stage Melanoma

Overview

About this study

The purpose of this study is to identify melanoma patients that have a pattern or cycle when the immune system is more active in fighting cancer cells and see if treating melanoma at certain times in that cycle may be more effective.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

History of early stage (stage I, II, or IIIA) malignant melanoma
History of curative surgical resection
Willingness to provide research blood samples
Age ≥18 years

Exclusion criteria:

Evidence of disease recurrence for ≤ one year
Pregnant or breast feeding women, or women of child-bearing potential (and/or their partners) who are unwilling to utilize an approved method of birth control during the study and for 1 month afterward

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Roxana Dronca, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Roxana Dronca, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials